ITI Pharma and Healthcare Fund Direct Growth

ITI Pharma and Healthcare Fund Direct Growth

Equity

ITI Mutual Fund

Sector - Healthcare

Get the latest NAV of ITI Pharma and Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹17.57

▲0.8%1D

NAV as on 27 Jun 2025

16.81%/per year

Since Inception

Absolute Gain%

▲▼

177 people have invested ₹ 6.8L in ITI Pharma and Healthcare Fund Direct Growth in the last three months

ITI Pharma and Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (27-Jun-25)

The fund has outperformed the benchmark (Nifty 500) over 1Y, 3Y, but underperformed over 5Y.

Period
This Fund
Nifty 500
Category Avg
1 Month
2.22%
3.52%
1.81%
3 Months
5.14%
10.33%
4.85%
6 Months
-4.37%
5.23%
-1.96%
1 Year
18.67%
4.8%
17.37%
3 Years
25.87%
20.66%
24.65%

Peer comparison

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
ITI Pharma and Healthcare Fund
-
221Cr
0.47%
18.67%
25.87%
16.81%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,689Cr
0.9%
21.24%
30.02%
18.23%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2/8
5,508Cr
1.06%
23.69%
30.57%
22.96%
Tata India Pharma & Healthcare Fund Direct Growth
3/8
1,232Cr
0.63%
16.82%
26.45%
14.01%
See all

ITI Pharma and Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

ITI Pharma and Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Jun-25)

Fund Distribution

as on (14-Jun-25)

Equity 99.7%

Debt & Cash 0.3%

Mid cap
34.9%
Small cap
33.2%
Large cap
30.5%
Small Cap allocation has gone up from 31.9% to 33.2%
Small Cap allocation has gone up from 31.9% to 33.2%
Mid Cap allocation has gone down from 35.3% to 34.9%
Mid Cap allocation has gone down from 35.3% to 34.9%
Large Cap allocation has gone up from 29.3% to 30.5%
Large Cap allocation has gone up from 29.3% to 30.5%
Cash allocation has gone down from 2.5% to 0.3%
Cash allocation has gone down from 2.5% to 0.3%

ITI Pharma and Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Jun-25)

Sector Allocation

Equity 99.7%

Debt & Cash 0.3%

Health
97.3%
Financial Services
1.5%
Basic Materials
1.2%

Top 3 Sectors in May were Health, Basic Materials & Industrial

May'25

Health

95%

Basic Materials

4%

Industrial

Apr'25

Health

96%

Basic Materials

3%

Industrial

1%

ITI Pharma and Healthcare Fund Holdings Details

as on (31-May-25)

Equity

Top Stocks bought last month
Divi's Laboratories Ltd's allocation increased from 6.23% to 9.12%
Divi's Laboratories Ltd's allocation increased from 6.23% to 9.12%
Wockhardt Ltd's allocation increased from 1.68% to 2.28%
Wockhardt Ltd's allocation increased from 1.68% to 2.28%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 2.87% to 3.15%
Aster DM Healthcare Ltd Ordinary Shares's allocation increased from 2.87% to 3.15%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 16.72 % to 15.18 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 16.72 % to 15.18 %
Lupin Ltd's allocation decreased from 5.83 % to 5.4 %
Lupin Ltd's allocation decreased from 5.83 % to 5.4 %
Apollo Hospitals Enterprise Ltd's allocation decreased from 5.31 % to 5.19 %
Apollo Hospitals Enterprise Ltd's allocation decreased from 5.31 % to 5.19 %

ITI Pharma and Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.47%
Benchmark
Nifty Healthcare TR INR
AUM₹221 Cr
Inception Date11 November, 2021
Min Lumpsum/SIP₹5000/₹500
Exit Load
0.5%
Lock InNo Lock-in
TurnOver
61.96%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About ITI Pharma and Healthcare Fund

ITI Pharma and Healthcare Fund Direct Growth is an equity fund. This fund was started on 11 November, 2021. The fund is managed by . The fund could potentially beat inflation in the long-run.

Key Parameters

  1. ITI Pharma and Healthcare Fund Direct Growth has ₹221 Cr worth of assets under management (AUM) as on Jun 2025 and is more than category average.
  2. The fund has an expense ratio 0.5.

Returns

ITI Pharma and Healthcare Fund Direct Growth has given a CAGR return of 16.81% since inception. Over the last 1 and 3 years the fund has given a CAGR return of 18.67% and 25.87% respectively.

Holdings

ITI Pharma and Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials, Industrial. Its top holdings are Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Max Healthcare Institute Ltd Ordinary Shares, Lupin Ltd, Apollo Hospitals Enterprise Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of ITI Pharma and Healthcare Fund Direct Growth

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. However, there can be no assurance that the investment objective of the scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. ITI Pharma and Healthcare Fund Direct Growth has no lock in period.

Learn more about ITI Mutual Fund
Parameters
May'25
Apr'25
Mar'25
AUM
₹ 220.8 Cr
₹ 219.1 Cr
₹ 213.8 Cr
  • AUM of the fund stands at 220.8 Cr as of May'25
  • AUM increased by 1.8 Cr between May'25 and Apr'25

Compare ITI Pharma and Healthcare Fund

ITI Pharma and Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for ITI Pharma and Healthcare Fund Direct Growth

How do I invest in ITI Pharma and Healthcare Fund?

INDmoney makes it simple to invest in the ITI Pharma and Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘ITI Pharma and Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of ITI Pharma and Healthcare Fund?

The NAV of the fund today is ₹17.57. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

ITI Pharma and Healthcare Fund fund has generated a return of 18.67% in 1 year, 25.87% in 3 years

Who is the fund manager of ITI Pharma and Healthcare Fund?

The fund managers are .

What is the exit load of the fund?

The exit load is 0.5% if redeemed in 0-3 Months. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 0.47%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹221 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of ITI Pharma and Healthcare Fund?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(15.18%), Divi's Laboratories Ltd(9.12%), Max Healthcare Institute Ltd Ordinary Shares(5.42%)